ArticleFrontiers in endocrinology2026
Ovarian function and X chromosome tissue mosaicism in adolescents with Turner syndrome and ongoing spontaneous puberty.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The maintenance of normal ovarian function depends on the presence of two structurally intact X chromosomes, which explains the high risk of premature ovarian insufficiency in individuals with Turner syndrome (TS). Most aneuploid germ cells undergo apoptosis during embryonic gonadal development, resulting in the formation of streak gonads in the majority of individuals with a 45,X karyotype. However, the role of X-monosomy in ovarian somatic cells, which provide the microenvironment essential for oocyte survival and development, remains poorly understood. To our knowledge, this is the first study to investigate the association between X chromosome aneuploidy in ovarian somatic cells and peripheral blood lymphocytes and ovarian function in adolescents with mosaic TS. The aim of this exploratory case-series study was to comprehensively evaluate the clinical, hormonal, ultrasonographic, morphological, morphometric, immunohistochemical, and molecular cytogenetic characteristics of the ovaries in adolescents with mosaic TS and spontaneous pubertal development. Methods: Five adolescents with mosaic TS underwent assessment of ovarian reserve markers and ovarian tissue cryopreservation. Follicle density (FD), expression of oocyte-specific markers (GDF9, BMP15, and CD117), and X chromosome mosaicism in 2-6 oocytes, 50-300 granulosa cells (GCs), and 50 ovarian stromal cells per participant were evaluated. Results: Despite ongoing puberty and normal gonadotropin levels, reduced serum anti-Müllerian hormone (AMH) and inhibin B concentrations were observed in some participants. A normal X chromosome complement was identified in all analyzed oocytes. Ovarian stromal cells were predominantly monosomic for the X chromosome, whereas GCs demonstrated substantial intra- and inter-individual variability in X chromosome mosaicism. No clear relationship was observed between X chromosome mosaicism in peripheral blood lymphocytes and ovarian tissue. Age-appropriate FD was observed only in participants whose follicles contained more than 60% non-monosomic GCs (XX or XXX). Discussion: The findings suggest that ovarian function in adolescents with mosaic TS may be associated not only with the chromosomal status of oocytes but also with that of GCs. Peripheral blood karyotype did not reliably reflect ovarian tissue mosaicism in this exploratory series, highlighting the importance of comprehensive evaluation of ovarian reserve markers when counseling patients with TS regarding fertility preservation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.